Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection.

Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, Fukuda MN, Fukuda M, Katsuyama T, Nakayama J.

Science. 2004 Aug 13;305(5686):1003-6.

2.

[Mechanism for the growth inhibition of Helicobacter pylori by gastric gland mucus-specific O-glycan].

Nakayama J, Kobayashi M, Fukuda M.

Tanpakushitsu Kakusan Koso. 2008 Sep;53(12 Suppl):1655-60. Review. Japanese. No abstract available.

PMID:
21089383
3.

Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection.

Kobayashi M, Lee H, Nakayama J, Fukuda M.

Curr Drug Metab. 2009 Jan;10(1):29-40. Review.

4.

Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.

Slomiany BL, Piotrowski J, Slomiany A.

Arzneimittelforschung. 1997 Apr;47(4A):475-82. Review.

PMID:
9205747
5.

Gastroprotective agents in mucosal defense against Helicobacter pylori.

Slomiany BL, Murty VL, Piotrowski J, Slomiany A.

Gen Pharmacol. 1994 Sep;25(5):833-41. Review.

PMID:
7835626
6.

Helicobacter pylori adhesion to gastric epithelial cells is mediated by glycan receptors.

Magalhães A, Reis CA.

Braz J Med Biol Res. 2010 Jul;43(7):611-8. Epub 2010 Jun 7. Review.

7.

Modification of Helicobacter pylori adhesion to human gastric epithelial cells by antiadhesion agents.

Hayashi S, Sugiyama T, Asaka M, Yokota K, Oguma K, Hirai Y.

Dig Dis Sci. 1998 Sep;43(9 Suppl):56S-60S. Review.

PMID:
9753227
8.

Of microbe and man: determinants of Helicobacter pylori-related diseases.

van Amsterdam K, van Vliet AH, Kusters JG, van der Ende A.

FEMS Microbiol Rev. 2006 Jan;30(1):131-56. Review.

9.

Bacterial factors that mediate colonization of the stomach and virulence of Helicobacter pylori.

Clyne M, Dolan B, Reeves EP.

FEMS Microbiol Lett. 2007 Mar;268(2):135-43. Review.

10.

[Pathogenesis of Helicobacter pylori infection--bacterium and host relationship].

Sokić-Milutinović A, Todorović V, Milosavljević T.

Srp Arh Celok Lek. 2004 Sep-Oct;132(9-10):340-4. Review. Serbian.

11.

Inflammation, immunity, vaccines for Helicobacter infection.

Chmiela M, Michetti P.

Helicobacter. 2006 Oct;11 Suppl 1:21-6. Review.

PMID:
16925607
12.

Novel intervention strategies for Helicobacter pylori treatment.

Noonan B, Alm RA.

Curr Drug Targets Infect Disord. 2002 Dec;2(4):331-8. Review.

PMID:
12570739
13.

Probiotics and Helicobacter pylori.

Felley C, Michetti P.

Best Pract Res Clin Gastroenterol. 2003 Oct;17(5):785-91. Review.

PMID:
14507588
14.

Microalgal compounds modulate carcinogenesis in the gastrointestinal tract.

Amaro HM, Barros R, Guedes AC, Sousa-Pinto I, Malcata FX.

Trends Biotechnol. 2013 Feb;31(2):92-8. doi: 10.1016/j.tibtech.2012.11.004. Epub 2012 Dec 19. Review.

PMID:
23260440
15.

Therapeutic potential of cholesteryl O-acyl α-glucoside found in Helicobacter pylori.

Shimamura M, Hidaka H.

Curr Med Chem. 2012;19(28):4869-74. Review.

PMID:
22934809
Items per page

Supplemental Content

Write to the Help Desk